We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Akzo Nobel NV (QX) | USOTC:AKZOY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.08 | 0.36% | 22.02 | 21.85 | 22.02 | 22.02 | 21.83 | 21.9145 | 24,129 | 19:04:32 |
From May 2019 to May 2024
Paints and specialty chemicals firm Akzo Nobel N.V. (AKZA.AE) said Thursday it and India's Atul Ltd. are exploring the feasibility of setting up a manufacturing joint venture to produce monochloroacetic acid, which is used in a wide variety of chemicals.
The Amsterdam-based company, which lists Dulux, Sikkens, Interpon and Eka among its brands, said two companies plan to install a plant at Atul's facility in Gujarat, subject to the necessary regulatory approvals.
The intended joint venture will use chlorine and hydrogen manufactured by Atul to produce monochloroacetic acid, taking advantage of Atul's existing infrastructure and AkzoNobel's latest eco-friendly hydrogenation technology.
Monochloroacetic acid is an essential building block in the chemical industry and is used to produce thickening agents for the food, oil, mining, personal care and detergent industries. It is also used in agrochemicals, adhesives, pharmaceuticals, thermo stabilizers, surfactants and cosmetics.
-Write to Ian Walker at ian.walker@wsj.com; @IanWalk40289749
(END) Dow Jones Newswires
April 28, 2016 06:14 ET (10:14 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
1 Year Akzo Nobel NV (QX) Chart |
1 Month Akzo Nobel NV (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
